接种与未接种新冠疫苗者的SARS-CoV-2病毒排出:病例系列
在聚集性场所疫情中,对12名感染者在感染前和感染期间隔日采集鼻拭子进行抗原检测和RT-PCR。12人中10人已完成新冠疫苗基础免疫,9/12(75%)鼻拭子病毒培养阳性;3例培养阴性者均已完成基础免疫;9名接种者中6例培养阳性,6名有症状者中3例在症状出现前培养阳性。
要点
- 12名感染者中10人(83%)已完成新冠疫苗基础免疫。
- 9/12(75%)鼻拭子标本病毒培养阳性。
- 3例病毒培养阴性者均已完成基础免疫。
核心结论
- 这些发现强调需要同时采取非药物干预和疫苗接种来减少传播。
研究设计与样本
- 在聚集性场所疫情中,对同意参与的感染者和暴露者隔日采集配对鼻中甲拭子进行抗原检测和逆转录聚合酶链反应(RT-PCR)。
- 在SARS-CoV-2感染前和感染期间前瞻性检测了12人。
主要发现
- 12名参与者中10人(83%)在疫情前已完成新冠疫苗基础免疫系列。
- 从9/12(75%)参与者的标本中通过病毒培养回收了SARS-CoV-2。
- 病毒培养未回收SARS-CoV-2的3人均已完成基础免疫系列。
- 9名接种者中6人病毒培养阳性;6名有症状者中3人在症状出现前病毒培养阳性。
临床怎么用
- 作者认为这些发现强调需要同时采取非药物干预和疫苗接种来减少传播。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The preclinical time course of SARS-CoV-2 shedding is not well-described. Understanding this time course will help to inform risk of SARS-CoV-2 transmission. During an outbreak in a congregate setting, we collected paired mid-turbinate nasal swabs for antigen testing and reverse-transcription polymerase chain reaction (RT-PCR) every other day from all consenting infected and exposed persons. Among 12 persons tested prospectively before and during SARS-CoV-2 infection, ten of 12 participants (83%) had completed a primary COVID-19 vaccination series prior to the outbreak. We recovered SARS-CoV-2 in viral culture from 9/12 (75%) of participants. All three persons from whom we did not recover SARS-CoV-2 in viral culture had completed their primary vaccination series. We recovered SARS-CoV-2 from viral culture in 6/9 vaccinated persons and before symptom onset in 3/6 symptomatic persons. These findings underscore the need for both non-pharmaceutical interventions and vaccination to mitigate transmission.
引用
- McCormick DW, Hagan LM, Salvatore PP, et al. SARS-CoV-2 viral shedding in vaccinated and unvaccinated persons: A case series. Vaccine. 2022. PMID: 36435706. doi:10.1016/j.vaccine.2022.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。